Your browser doesn't support javascript.
loading
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Tachiki, Lisa May Ling; Hippe, Daniel S; Williams Silva, Karly; Hall, Evan Thomas; McCamy, William; Fritzsche, Dane; Perdue, Andrea; Majovski, Julia; Pulliam, Thomas; Goldstein, Daniel A; Veatch, Joshua; Ho, Joel; Nghiem, Paul T; Thompson, John A; Bhatia, Shailender.
Afiliación
  • Tachiki LML; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. ltachiki@uw.edu.
  • Hippe DS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. ltachiki@uw.edu.
  • Williams Silva K; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Hall ET; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
  • McCamy W; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Fritzsche D; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
  • Perdue A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Majovski J; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
  • Pulliam T; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Goldstein DA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
  • Veatch J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Ho J; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
  • Nghiem PT; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Thompson JA; Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA.
  • Bhatia S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Cancer Immunol Immunother ; 72(11): 3839-3850, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37733060
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos